Clinical Potential of UTE‐MRI for Assessing COVID‐19: Patient‐ and Lesion‐Based Comparative Analysis

Abstract

and Turkey all have more than 100 000 cumulative confirmed cases. 1 A worldwide consensus has been reached that this is an unprecedented human public health emergency. At present, real-time reverse transcription polymerase chain reaction (RT-PCR) is accepted as the standard diagnostic criterion for COVID-19. 2 Nevertheless, 1) it's difficult to address the challenges caused by the surge in diagnostic

Thorax Magnetic Resonance Imaging Findings in Patients with Coronavirus Disease (COVID-19)

“…In this study, similar to our study, a perfect match was found between MRI findings and CT findings. However, the most important difference of this study from our study is that no patient with a nodule was included in the study (12). There are also two case reports in the literature regarding the MRI findings of COVID-19.…”

Editorial for “Clinical Potential of UTE‐MRI for Assessing the COVID‐19: Patient‐ and Lesion‐Based Comparative Analysis”

“…Second, that given the ultrashort echo time, UTE-MRI is capable of compromising the fast T 2 * signal decay, which improves the signal-to-noise ratio of images. 8 Both the lesion-and patient-based comparative analyses demonstrated high concordance between UTE-MRI and CT for detecting typical pulmonary lesions including ground glass opacities (GGO), consolidation, GGO with consolidation, axial location, anteroposterior location, the number of affected lobes, the number of crazy-paving patterns, and the number of linear opacities. However, the lesion-based intermethod agreements for evaluating secondary signs such as air bronchogram, pseudocavity, and crazy-paving patterns were between fair and moderate.…”

“…In this issue of JMRI, Yang et al 8 report the results from a prospective study that aimed to evaluate the clinical potential of ultrashort echo time magnetic resonance imaging (UTE-MRI) for the assessment of COVID-19 using CT as the reference method. The study incorporated both lesionbased and patient-based comparative analyses, in addition to assessments of image quality.…”

“…The study incorporated both lesionbased and patient-based comparative analyses, in addition to assessments of image quality. 8 The study sample comprised 23 patients with confirmed COVID-19 according to RT-PCR, and there was an average interval of 2.81 days between the admission of patients to hospital and image examination.…”

“…However, the lesion-based intermethod agreements for evaluating secondary signs such as air bronchogram, pseudocavity, and crazy-paving patterns were between fair and moderate. 8 MRI is not considered to be a relevant tool in the routine, diagnostic work-up for lung disorders, even during the COVID-19 pandemic. Although MRI might be able to detect pneumonia with a high diagnostic accuracy, as shown in this article, there is no evidence of the advantages for use in this pathology, especially in an acute setting.…”